Cite
MLA Citation
Thomas S. J. Crabtree et al.. “Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists.” Diabetes, obesity & metabolism, vol. 24, no. 7, 2022, pp. 1398–1401. http://access.bl.uk/ark:/81055/vdc_100156460819.0x000021